De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity
about
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
P2860
De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@ast
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@en
type
label
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@ast
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@en
prefLabel
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@ast
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@en
P2093
P2860
P356
P1433
P1476
De novo diffuse large B-cell l ...... ion with rituximab sensitivity
@en
P2093
Akihiro Tomita
Chisako Iriyama
Hiroki Mizuno
Hitoshi Kiyoi
Kazuyuki Shimada
Keiki Sugimoto
Mizuho Shirahata-Adachi
Naoko Asano
Shigeo Nakamura
Takashi Tokunaga
P2860
P356
10.1111/CAS.12307
P577
2013-12-22T00:00:00Z